Results 171 to 180 of about 63,092 (214)

The epidemiology of SARS-CoV-2, Influenza, and Respiratory Syncytial Virus circulation among adult patients with acute respiratory illness in Kampala Metropolitan Area in Uganda. [PDF]

PLoS One
Arinaitwe J, Bakamutumaho B, Mugenyi L, Kiwanuka N, Alupo P, Kawuma AN, Ndahura K, Sekimpi M, Akurut E, Muttamba W, Joloba M, Ocan M, Wampande E, Kyosiimire Lugemwa J, Nakibuuka J, Lusiba J, Okia J, Owachi D, Byakika-Kibwika P, Kirenga B.   +19 more
europepmc   +1 more source

Respiratory syncytial virus-induced SIGLEC1 upregulation inhibits macrophage autophagy and facilitates inflammatory mediator secretion. [PDF]

BMJ Open Respir Res
Lai F, Liao A, Xia K, Zhang L, Yang H, Lin W.   +5 more
europepmc   +1 more source

High rates of viral co-detection in outpatient children with acute respiratory infections after the easing of preventive measures against Covid-19 in Germany. [PDF]

BMC Infect Dis
Haufschild A, Niekler P, Sack J, Weissbrich B, Knies K, Härtel C, Streng A, Dölken L, Liese JG, Engels G, CoPraKid 2.0 Study Group.   +10 more
europepmc   +1 more source

Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.

JAMA Netw Open
Rick AM, Deese J, Kerr JE, Hui J, Liu H, Yu G, Chang CH, Fazio N, Tahir MH, Bieltz R, Ravindra A, Megli C, Jeyabalan A, Pugh SJ, Patel D, Fan R, Atwell JE, Cané A, Martin JM.   +18 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Respiratory syncytial virus interaction with human airway epithelium

Trends in Microbiology, 2013
Although respiratory syncytial virus (RSV) is a major human respiratory pathogen, our knowledge of how it causes disease in humans is limited. Airway epithelial cells are the primary targets of RSV infection in vivo, so the generation and exploitation of RSV infection models based on morphologically and physiologically authentic well-differentiated ...
Rémi Villenave, Michael D Shields, Ultan F Power   +2 more
exaly   +4 more sources

Pharmacological management of human respiratory syncytial virus infection

Expert Opinion on Pharmacotherapy, 2020
Human respiratory syncytial virus (hRSV) is the primary viral cause of respiratory diseases, leading to bronchiolitis and pneumonia in vulnerable populations. The only current treatment against this virus is palliative, and no efficient and specific vaccine against this pathogen is available.The authors describe the disease symptoms caused by hRSV, the
Alexis M Kalergis, Jorge A Soto, Nicolas M S Galvez   +2 more
exaly   +4 more sources

HUMAN RESPIRATORY SYNCYTIAL VIRUS

2023
Human Respiratory Syncytial Virus (RSV) has a significant role in the development of newborns' and children's' respiratory tract illnesses. It causes serious lower respiratory tract infections in newborns and young children. RSV causes widespread outbreaks of illness each year during the winter season. in the winter months of November through March RSV
Anto P V, Vidyaa Nayaki, Vignesh Kanna Balaji   +2 more
openaire   +1 more source

Human Respiratory Syncytial Virus: An Introduction

2016
Human respiratory syncytial virus (RSV) is understood to be a significant human pathogen in infants, young children, and the elderly and the immunocompromised. Over the last decade many important mechanisms contributing to RSV infection, replication, and disease pathogenesis have been revealed; however, there is still insufficient knowledge which has ...
Patricia A, Jorquera, Lydia, Anderson, Ralph A, Tripp   +2 more
openaire   +2 more sources